glp-1 incretin effect GIP and GLP‐1, the two hormones: Similarities and differences GLP-1 receptor agonists are increasingly

The most commonly reported adverse events (observed in greater than 5% of clinical trial participants) were nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, injection-site reactions, fatigue, hypersensitivity reactions, eructation, hair loss and gastroesophageal reflux disease

Initially, it was a modest tool in the diabetes arsenal: enhanced insulin release, suppressed glucagon, slowed gastric emptying

Hydration status: Nausea and reduced oral intake can lead to dehydration, potentially causing acute kidney injury, particularly in older adults

Next-generation weight management solution to reduce food cravings, promote feeling full more quickly, and keep you feeling satisfied longer by activating multiple GLP-1 receptors

Frequent weigh-ins and body composition scans detect shifts early

Absolutely, GLP 1 & GIP therapy requires special care regarding its source, handling and the quality grade of the ingredients